(Q40921135)

24 September 2017

1 reference

title

Lung disease in systemic sclerosis (scleroderma). (English)

1 reference

24 September 2017

1 reference

Bolster MB

1

1 reference

PubMed ID

8519079

24 September 2017

Silver RM

series ordinal

2

1 reference

24 September 2017

1 February 1993

1 reference

Bailliere's clinical rheumatology

24 September 2017

1 reference

24 September 2017

7

1 reference

24 September 2017

1

1 reference

24 September 2017

79-97

1 reference

Predictors of survival in systemic sclerosis (scleroderma)

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Small airways in progressive systemic sclerosis (PSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Respiratory Function in Progressive Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Serial Changes in Scleroderma and Idiopathic Interstitial Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Esophageal Motility and Pulmonary Function in Progressive Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Late features of toxic syndrome due to denatured rapeseed oil

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Structural features of interstitial lung disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Lung function in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Steroid-responsive interstitial pulmonary disease in systemic sclerosis. Monitoring by bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Smooth muscle actin is expressed by air space fibroblast-like cells in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

A multisystemic disease caused by adulterated rapeseed oil.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome. Analysis of fourteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Acute diffuse interstitial pulmonary fibrosis in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Some Basic and Clinical Challenges in the Pulmonary Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Isolated diffusing capacity reduction in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Acute eosinophilic pulmonary disease associated with the ingestion of L-tryptophan-containing products

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Failure of vasodilator infusion to alter pulmonary diffusing capacity in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pulmonary scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Pulmonary vascular changes in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

The pulmonary pathologic manifestations of the CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

Retrospective studies in scleroderma: pulmonary findings and effect of potassium p-aminobenzoate on vital capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980269-9

7 January 2021

10.1016/S0950-3579(05)80269-9

Identifiers

DOI

1 reference

release_aygdkvqdbbhwjlpsv4haskx7xm

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aygdkvqdbbhwjlpsv4haskx7xm

24 November 2022

mapped directly with Wikidata item

PubMed ID

8519079

1 reference

PubMed ID

8519079